IL15 and melanoma: Assuming that ACT of TRP-1-specific CD4+ T cells could reject established melanoma tumors in IL-15−/−RAG−/− mice, we could use this model to dissect the activity of NK cells on adoptively transferred CD4+ T cells without also activating Fc receptors.